A Bayesian longitudinal model for imputing item-level missing data in trial-based economic evaluations that accommodates these complexities within a unified framework is developed and can be extended to settings where data may be missing not at random.
Abstract
Trial-based economic evaluations are widely used to assess the cost-effectiveness of healthcare interventions and inform decision-making. Cost and effectiveness outcomes are typically collected using multi-item questionnaires administered at multiple time points, and are often subject to item-level missingness. In principle, imputation (i.e., replacing missing value with estimated or substituted values) should be performed at the item level to fully exploit available information. However, this is rarely implemented in practice due to several statistical challenges, including the longitudinal data structure, cross-item dependence, heterogeneous missingness patterns, and the mixture of skewed cost and count data. In this paper, we develop a Bayesian longitudinal model for imputing item-level missing data in trial-based economic evaluations that accommodates these complexities within a unified framework. The approach combines a transition-model formulation for longitudinal dependence with flexible distributional assumptions and explicit modelling of cross-item relationships, allowing item-level responses of different types to be coherently modelled over time. Motivated by a real-world trial, we demonstrate the flexibility and practical applicability of the proposed approach. We further discuss how the model can be extended to settings where data may be missing not at random.
Differences between item-level and score-level imputation were generally modest, although score-level imputation tended to yield slightly lower RMSE and bias magnitudes under more severe missingness conditions.
C. Veltri, U. Grittner, P. Gebert· BMC Medical Research Methodo...· 0 citations
For model comparison in random effects probit models with incompletely observed covariates, this paper develops a Bayesian data-augmentation workflow in which latent Gaussian responses, random effects, and missing covariate values are updated within a common augmented sampling scheme. Because specifying a fully param...
Michael Bergrab· Statistical Methods & Ap...· 0 citations
Biomedical studies often collect mixed-type longitudinal data (e.g., clinical, lifestyle) to identify predictors of a binary health outcome. A common analytical challenge is to link these irregularly collected variables to the outcome, particularly when the number of potential predictors is large. While joint models (J...
Lingpeng Shan, Michelle J. Naughton, E. Paskett et al.· Statistical Methods in Medic...· 0 citations
Background: Length and quality of life are frequently combined in health technology assessments to derive a single, generic measure of health improvement due to a treatment or medicine. One such measure is given by quality-adjusted life-years (QALYs), typically calculated assuming discrete health states and quality-of-...
M. Crowther, Alessandro Gasparini, Sara Ekberg et al.· Medical decision making· 0 citations
Intensive longitudinal data (ILD) are commonly used to study within-person processes, and psychometric methods for computing within-person reliability with ILD have recently appeared in the methodological literature. The dense, frequent nature of data collection in ILD often leads to copious amounts of missing data-rec...
Daniel McNeish· Psychological methods· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.